Form IRB2-1 Irb2 Adverse Event & Unanticipated Problem Report - Texas

Form IRB2-1 Irb2 Adverse Event & Unanticipated Problem Report - Texas

What Is Form IRB2-1?

This is a legal form that was released by the Texas Health and Human Services - a government authority operating within Texas. As of today, no separate filing guidelines for the form are provided by the issuing department.

FAQ

Q: What is IRB2-1?
A: IRB2-1 is a form for reporting adverse events and unanticipated problems in Texas.

Q: What is the purpose of form IRB2-1?
A: The purpose of form IRB2-1 is to report adverse events and unanticipated problems related to research studies.

Q: Who is required to complete form IRB2-1?
A: Researchers conducting research studies in Texas are required to complete form IRB2-1.

Q: What should be reported on form IRB2-1?
A: Form IRB2-1 should be used to report any adverse events or unanticipated problems that occur during the course of a research study.

Q: How should form IRB2-1 be submitted?
A: Form IRB2-1 should be submitted to the Institutional Review Board (IRB) of the institution where the research study is being conducted.

ADVERTISEMENT

Form Details:

  • Released on August 14, 2019;
  • The latest edition provided by the Texas Health and Human Services;
  • Easy to use and ready to print;
  • Quick to customize;
  • Compatible with most PDF-viewing applications;
  • Fill out the form in our online filing application.

Download a fillable version of Form IRB2-1 by clicking the link below or browse more documents and templates provided by the Texas Health and Human Services.

Download Form IRB2-1 Irb2 Adverse Event & Unanticipated Problem Report - Texas

4.3 of 5 (11 votes)
  • Form IRB2-1 Irb2 Adverse Event & Unanticipated Problem Report - Texas

    1

  • Form IRB2-1 Irb2 Adverse Event & Unanticipated Problem Report - Texas, Page 2

    2

  • Form IRB2-1 Irb2 Adverse Event  Unanticipated Problem Report - Texas, Page 1
  • Form IRB2-1 Irb2 Adverse Event  Unanticipated Problem Report - Texas, Page 2
Prev 1 2 Next
ADVERTISEMENT